Skip to main content

Equibles does not estimate personal net worth.

Get an email with a short summary when Edesa Biotech, Inc. publishes a filing, an earnings call transcript or a press release.

Get EDSA alerts

About Michael Brooks

The proxy statement of Edesa Biotech, Inc. reports total compensation of $861,877 for Michael Brooks in fiscal 2025, including a base salary of $335,340. Disclosed compensation is on record for 5 fiscal years. Edesa Biotech, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Edesa Biotech, Inc. includes Pardeep Nijhawan (CEO and Board Member), Carlo Sistilli (Chairman and Board Member), Peter J. Weiler (CFO) and 7 others.

Affiliation history

Company network

Leadership on record at Edesa Biotech, Inc.

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2025 Edesa Biotech, Inc. (EDSA) $335,340 $861,877
2024 Edesa Biotech, Inc. (EDSA) $335,340 $428,987
2023 Edesa Biotech, Inc. (EDSA) $320,054 $488,762
2020 Edesa Biotech, Inc. (EDSA) $275,000 $529,211
2019 Edesa Biotech, Inc. (EDSA) $158,114 $207,254

Recent activity

No call appearances or filed executive changes recorded yet.